Cargando…

Risk modeling in transcatheter aortic valve replacement remains unsolved: an external validation study in 2946 German patients

BACKGROUND: Surgical risk prediction models are routinely used to guide decision-making for transcatheter aortic valve replacement (TAVR). New and updated TAVR-specific models have been developed to improve risk stratification; however, the best option remains unknown. OBJECTIVE: To perform a compar...

Descripción completa

Detalles Bibliográficos
Autores principales: Wolff, Georg, Shamekhi, Jasmin, Al-Kassou, Baravan, Tabata, Noriaki, Parco, Claudio, Klein, Kathrin, Maier, Oliver, Sedaghat, Alexander, Polzin, Amin, Sugiura, Atsushi, Jung, Christian, Grube, Eberhard, Westenfeld, Ralf, Icks, Andrea, Zeus, Tobias, Sinning, Jan-Malte, Baldus, Stephan, Nickenig, Georg, Kelm, Malte, Veulemans, Verena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907023/
https://www.ncbi.nlm.nih.gov/pubmed/32851491
http://dx.doi.org/10.1007/s00392-020-01731-9
_version_ 1783655408929341440
author Wolff, Georg
Shamekhi, Jasmin
Al-Kassou, Baravan
Tabata, Noriaki
Parco, Claudio
Klein, Kathrin
Maier, Oliver
Sedaghat, Alexander
Polzin, Amin
Sugiura, Atsushi
Jung, Christian
Grube, Eberhard
Westenfeld, Ralf
Icks, Andrea
Zeus, Tobias
Sinning, Jan-Malte
Baldus, Stephan
Nickenig, Georg
Kelm, Malte
Veulemans, Verena
author_facet Wolff, Georg
Shamekhi, Jasmin
Al-Kassou, Baravan
Tabata, Noriaki
Parco, Claudio
Klein, Kathrin
Maier, Oliver
Sedaghat, Alexander
Polzin, Amin
Sugiura, Atsushi
Jung, Christian
Grube, Eberhard
Westenfeld, Ralf
Icks, Andrea
Zeus, Tobias
Sinning, Jan-Malte
Baldus, Stephan
Nickenig, Georg
Kelm, Malte
Veulemans, Verena
author_sort Wolff, Georg
collection PubMed
description BACKGROUND: Surgical risk prediction models are routinely used to guide decision-making for transcatheter aortic valve replacement (TAVR). New and updated TAVR-specific models have been developed to improve risk stratification; however, the best option remains unknown. OBJECTIVE: To perform a comparative validation study of six risk models for the prediction of 30-day mortality in TAVR METHODS AND RESULTS: A total of 2946 patients undergoing transfemoral (TF, n = 2625) or transapical (TA, n = 321) TAVR from 2008 to 2018 from the German Rhine Transregio Aortic Diseases cohort were included. Six surgical and TAVR-specific risk scoring models (LogES I, ES II, STS PROM, FRANCE-2, OBSERVANT, GAVS-II) were evaluated for the prediction of 30-day mortality. Observed 30-day mortality was 3.7% (TF 3.2%; TA 7.5%), mean 30-day mortality risk prediction varied from 5.8 ± 5.0% (OBSERVANT) to 23.4 ± 15.9% (LogES I). Discrimination performance (ROC analysis, c-indices) ranged from 0.60 (OBSERVANT) to 0.67 (STS PROM), without significant differences between models, between TF or TA approach or over time. STS PROM discriminated numerically best in TF TAVR (c-index 0.66; range of c-indices 0.60 to 0.66); performance was very similar in TA TAVR (LogES I, ES II, FRANCE-2 and GAVS-II all with c-index 0.67). Regarding calibration, all risk scoring models—especially LogES I—overestimated mortality risk, especially in high-risk patients. CONCLUSIONS: Surgical as well as TAVR-specific risk scoring models showed mediocre performance in prediction of 30-day mortality risk for TAVR in the German Rhine Transregio Aortic Diseases cohort. Development of new or updated risk models is necessary to improve risk stratification. GRAPHIC ABSTRACT: [Image: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00392-020-01731-9) contains supplementary material, which is available to authorized users.
format Online
Article
Text
id pubmed-7907023
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Springer Berlin Heidelberg
record_format MEDLINE/PubMed
spelling pubmed-79070232021-03-09 Risk modeling in transcatheter aortic valve replacement remains unsolved: an external validation study in 2946 German patients Wolff, Georg Shamekhi, Jasmin Al-Kassou, Baravan Tabata, Noriaki Parco, Claudio Klein, Kathrin Maier, Oliver Sedaghat, Alexander Polzin, Amin Sugiura, Atsushi Jung, Christian Grube, Eberhard Westenfeld, Ralf Icks, Andrea Zeus, Tobias Sinning, Jan-Malte Baldus, Stephan Nickenig, Georg Kelm, Malte Veulemans, Verena Clin Res Cardiol Original Paper BACKGROUND: Surgical risk prediction models are routinely used to guide decision-making for transcatheter aortic valve replacement (TAVR). New and updated TAVR-specific models have been developed to improve risk stratification; however, the best option remains unknown. OBJECTIVE: To perform a comparative validation study of six risk models for the prediction of 30-day mortality in TAVR METHODS AND RESULTS: A total of 2946 patients undergoing transfemoral (TF, n = 2625) or transapical (TA, n = 321) TAVR from 2008 to 2018 from the German Rhine Transregio Aortic Diseases cohort were included. Six surgical and TAVR-specific risk scoring models (LogES I, ES II, STS PROM, FRANCE-2, OBSERVANT, GAVS-II) were evaluated for the prediction of 30-day mortality. Observed 30-day mortality was 3.7% (TF 3.2%; TA 7.5%), mean 30-day mortality risk prediction varied from 5.8 ± 5.0% (OBSERVANT) to 23.4 ± 15.9% (LogES I). Discrimination performance (ROC analysis, c-indices) ranged from 0.60 (OBSERVANT) to 0.67 (STS PROM), without significant differences between models, between TF or TA approach or over time. STS PROM discriminated numerically best in TF TAVR (c-index 0.66; range of c-indices 0.60 to 0.66); performance was very similar in TA TAVR (LogES I, ES II, FRANCE-2 and GAVS-II all with c-index 0.67). Regarding calibration, all risk scoring models—especially LogES I—overestimated mortality risk, especially in high-risk patients. CONCLUSIONS: Surgical as well as TAVR-specific risk scoring models showed mediocre performance in prediction of 30-day mortality risk for TAVR in the German Rhine Transregio Aortic Diseases cohort. Development of new or updated risk models is necessary to improve risk stratification. GRAPHIC ABSTRACT: [Image: see text] ELECTRONIC SUPPLEMENTARY MATERIAL: The online version of this article (10.1007/s00392-020-01731-9) contains supplementary material, which is available to authorized users. Springer Berlin Heidelberg 2020-08-26 2021 /pmc/articles/PMC7907023/ /pubmed/32851491 http://dx.doi.org/10.1007/s00392-020-01731-9 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Original Paper
Wolff, Georg
Shamekhi, Jasmin
Al-Kassou, Baravan
Tabata, Noriaki
Parco, Claudio
Klein, Kathrin
Maier, Oliver
Sedaghat, Alexander
Polzin, Amin
Sugiura, Atsushi
Jung, Christian
Grube, Eberhard
Westenfeld, Ralf
Icks, Andrea
Zeus, Tobias
Sinning, Jan-Malte
Baldus, Stephan
Nickenig, Georg
Kelm, Malte
Veulemans, Verena
Risk modeling in transcatheter aortic valve replacement remains unsolved: an external validation study in 2946 German patients
title Risk modeling in transcatheter aortic valve replacement remains unsolved: an external validation study in 2946 German patients
title_full Risk modeling in transcatheter aortic valve replacement remains unsolved: an external validation study in 2946 German patients
title_fullStr Risk modeling in transcatheter aortic valve replacement remains unsolved: an external validation study in 2946 German patients
title_full_unstemmed Risk modeling in transcatheter aortic valve replacement remains unsolved: an external validation study in 2946 German patients
title_short Risk modeling in transcatheter aortic valve replacement remains unsolved: an external validation study in 2946 German patients
title_sort risk modeling in transcatheter aortic valve replacement remains unsolved: an external validation study in 2946 german patients
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7907023/
https://www.ncbi.nlm.nih.gov/pubmed/32851491
http://dx.doi.org/10.1007/s00392-020-01731-9
work_keys_str_mv AT wolffgeorg riskmodelingintranscatheteraorticvalvereplacementremainsunsolvedanexternalvalidationstudyin2946germanpatients
AT shamekhijasmin riskmodelingintranscatheteraorticvalvereplacementremainsunsolvedanexternalvalidationstudyin2946germanpatients
AT alkassoubaravan riskmodelingintranscatheteraorticvalvereplacementremainsunsolvedanexternalvalidationstudyin2946germanpatients
AT tabatanoriaki riskmodelingintranscatheteraorticvalvereplacementremainsunsolvedanexternalvalidationstudyin2946germanpatients
AT parcoclaudio riskmodelingintranscatheteraorticvalvereplacementremainsunsolvedanexternalvalidationstudyin2946germanpatients
AT kleinkathrin riskmodelingintranscatheteraorticvalvereplacementremainsunsolvedanexternalvalidationstudyin2946germanpatients
AT maieroliver riskmodelingintranscatheteraorticvalvereplacementremainsunsolvedanexternalvalidationstudyin2946germanpatients
AT sedaghatalexander riskmodelingintranscatheteraorticvalvereplacementremainsunsolvedanexternalvalidationstudyin2946germanpatients
AT polzinamin riskmodelingintranscatheteraorticvalvereplacementremainsunsolvedanexternalvalidationstudyin2946germanpatients
AT sugiuraatsushi riskmodelingintranscatheteraorticvalvereplacementremainsunsolvedanexternalvalidationstudyin2946germanpatients
AT jungchristian riskmodelingintranscatheteraorticvalvereplacementremainsunsolvedanexternalvalidationstudyin2946germanpatients
AT grubeeberhard riskmodelingintranscatheteraorticvalvereplacementremainsunsolvedanexternalvalidationstudyin2946germanpatients
AT westenfeldralf riskmodelingintranscatheteraorticvalvereplacementremainsunsolvedanexternalvalidationstudyin2946germanpatients
AT icksandrea riskmodelingintranscatheteraorticvalvereplacementremainsunsolvedanexternalvalidationstudyin2946germanpatients
AT zeustobias riskmodelingintranscatheteraorticvalvereplacementremainsunsolvedanexternalvalidationstudyin2946germanpatients
AT sinningjanmalte riskmodelingintranscatheteraorticvalvereplacementremainsunsolvedanexternalvalidationstudyin2946germanpatients
AT baldusstephan riskmodelingintranscatheteraorticvalvereplacementremainsunsolvedanexternalvalidationstudyin2946germanpatients
AT nickeniggeorg riskmodelingintranscatheteraorticvalvereplacementremainsunsolvedanexternalvalidationstudyin2946germanpatients
AT kelmmalte riskmodelingintranscatheteraorticvalvereplacementremainsunsolvedanexternalvalidationstudyin2946germanpatients
AT veulemansverena riskmodelingintranscatheteraorticvalvereplacementremainsunsolvedanexternalvalidationstudyin2946germanpatients